Erika Hamilton: ADCs are changing breast cancer care
Erika Hamilton, Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on LinkedIn:
“In anticipation of SABCS24, what better time to highlight our patients?
The reason we do what we do every day.
CURE magazine highlighted one of my patients in a fantastic story about how ADCs are changing breast cancer care.
Karen is the best, 16 years alive with metastatic HER-2 positive breast cancer and still going strong.
Makes me happy every single day.”
Title: Finding Hope With Antibody-Drug Conjugates in Managing Breast Cancer
Author: Alex Biese
Erika Hamilton is a medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research Institute (USA). Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee. She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.
More posts featuring Erika Hamilton.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023